- Macro Strategist
Skip to main content
- Funds
- Insights
- Capabilities
- About Us
- My Account
Our Funds
Fund Documents
Global Multi-Strategy Fund
The views expressed are those of the author at the time of writing. Other teams may hold different views and make different investment decisions. The value of your investment may become worth more or less than at the time of original investment. While any third-party data used is considered reliable, its accuracy is not guaranteed. For professional, institutional, or accredited investors only.
I recently visited India for two weeks and was struck by how much has changed, predominantly for the better, in terms of its macroeconomic picture. With that in mind, here are my latest thoughts on the macro environment, along with my high-level take on India’s equity market.
On Indian equities, I think the catalysts of cleaner company balance sheets and strengthening business and consumer demand augur well for both nominal gross domestic product (GDP) and corporate earnings growth. I see India’s economy as being in much better shape structurally than it was pre-pandemic and expect GDP growth of around 7% for full-year 2022, followed by annual growth in the neighborhood of 6% – 7% over the next few years. Rising interest rates are a potential headwind, but I suspect the Reserve Bank of India will be unlikely to hike rates too aggressively for fear of dampening demand and growth.
Bottom line: While overall market valuation has been quite elevated lately, I continue to believe discerning investors should look for opportunities to “buy the dips” in India’s equity market going forward. While not my base, the biggest risk to my view is a large and sustained upward move in commodity prices, which could adversely affect India’s current and fiscal accounts and push broader inflation even higher.
US exceptionalism: 5 perspectives on 2 truths
Continue readingInvestment insights on the Middle East: A roundtable discussion
Continue readingThe Fed’s growing footprint on the market has a cost
Continue readingHow to reposition equity portfolios for recurring AI disruption
Continue readingHousing affordability directives not a silver bullet
Continue readingJapan biopharma: A global sector priced as domestic
Continue readingURL References
Related Insights
US exceptionalism: 5 perspectives on 2 truths
Our experts discuss the paradox of US exceptionalism today, emphasizing diversification and active management in response to evolving global economic trends.
Investment insights on the Middle East: A roundtable discussion
In a special roundtable discussion, our investment experts discuss the Middle East crisis, including geopolitical developments, energy prices, emerging markets, and multi-asset implications.
Perspectives on the Middle East conflict
As the situation in the Middle East continues to unfold, you can find the latest insights from our investment experts here.
The Fed’s growing footprint on the market has a cost
Brij Khurana explains what the Federal Reserve's balance sheet expansion may mean for inflation and asset prices.
How to reposition equity portfolios for recurring AI disruption
With a growing range of industries hit by sell-offs, Multi-Asset Strategist Nanette Abuhoff Jacobson explores how to reposition equity portfolios for recurring AI disruption.
Housing affordability directives not a silver bullet
Our Fixed Income Portfolio Managers profile housing affordability directives, examining their modest effects on mortgage rates and institutional buying restrictions.
Japan biopharma: A global sector priced as domestic
Our biopharma experts discuss the global earnings potential of Japanese companies and highlight the need for a global investment lens.
Warsh as Fed chair: Something for everyone
Macro Strategist Juhi Dhawan shares five key takeaways on Kevin Warsh, President Trump’s nominee to be the next Fed chair, including thoughts on interest rates, deregulation, and the market impact.
JPY intervention: what makes it so important this time?
Fixed Income Portfolio Managers Sam Hogg and Ed Meyi and Investment Director Takashi Nakao explore what’s different about the unconfirmed but likely JPY intervention and why it matters for global investors.
Portfolio construction and volatility management in 2026
Multi-Asset Strategist Nanette Abuhoff Jacobson discusses adapting portfolios for 2026, focusing on diversification, hedge funds, and private markets.
URL References
Related Insights
Quarterly Market Review — 4Q2025
A monthly update on equity, fixed income, currency, and commodity markets.
By